Liothyronine Sodium
規格
55-06-1CAS番号
200-223-5EC番号
sodium (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoateIUPAC名
C15H11I3NNaO4化学式
672.95 g/mol分子量
LIOTHYRONINE SODIUM; 55-06-1; 3,3',5-Triiodo-L-thyronine sodium salt; Triostat; Basoprocin; Ibiothyron; T3 sodium salt; Cynomel; L-Triiodothyronine sodium salt; Cytobin; Liothyronine sodium salt; 3,3',5-Triiodo-L-thyronine sodium; Liotrix (t3); Triiodothyronine Sodium Salt; 3,3',5-Triiodothyronine sodium salt; Lyothyronin; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, monosodium salt; GCA9VV7D2N; Rathyronine sodium, (s)-; CHEBI:6484; Monosodium L-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; NSC-80774; NSC-758175; L-triiodothyronine hydrochloride; Rathyronine hydrochloride, (s)-; Alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, monosodium salt, L-; THYBON; Cytobin Tablets; Triiodothyronine,evans; RefChem:55512; Monosodium O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosinate; 200-223-5; Cytomel; Liothyronin sodium; Triiodothyronine sodium; MFCD00002594; DTXSID8047505; Liothyronine (sodium); LIOTHYRONINE (L- isomer) SODIUM; sodium (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate; Cytomel sodium; sodium (S)-2-amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoate; 3,3'',5-Triiodo-L-thyronine Sodium Salt; Ro thyronine; Sodium triiodothyronine; Sodium liothyronine; Sodium T3; Sodium triiodotironine; Sodium-L-triiodothyronine; MLS000028648; Sodium triiodothyronine, L-; 3,5,3'-Triiodo-L-thyronine monosodium salt; Sodium 3,5,3'-triiodothyronine; Sodium L-3,5,3'-triiodothyronine; SMR000059206; EINECS 200-223-5; UNII-GCA9VV7D2N; NSC 80774; Sodium 3,3',5-triiodo-L-thyronine; Sodium 3,5,3'-triiodo-L-thyronine; L-3,3',5-Triiodothyronine sodium salt; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine sodium salt; Triostat (TN); Cytomel (TN); Liothyronine sodium [USP:BAN:JAN]; Liothyronine sodium?; IBIOT; Liothyronine sodium RS; Liothyronine sodium CRS; sodium;(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate; T-3; Epitope ID:136777; T3 (LIOTRIX); SCHEMBL41654; MSK10002Na; 3,3',5-L-Triiodothyronine; SPECTRUM1502047; orb1224699; orb1307826; CHEMBL1201119; DTXCID6027505; SCHEMBL29378991; HY-A0070R; LIOTHYRONINE SODIUM [JAN]; NRP-409; Liothyronine (sodium) (Standard); Liothyronine sodium (JP18/USP); SBXXSUDPJJJJLC-YDALLXLXSA-M; HMS1921H18; HMS2092B14; LIOTHYRONINE SODIUM [VANDF]; HY-A0070; LIOTHYRONINE SODIUM [MART.]; Tox21_302514; CCG-39522; LIOTHYRONINE SODIUM [USP-RS]; LIOTHYRONINE SODIUM [WHO-DD]; LIOTRIX (T3) [ORANGE BOOK]; LIOTHYRONINE SODIUM SALT [MI]; AKOS015918421; AKOS032949712; CS-3241; EBC-102216; FT28507; CAS-55-06-1; Liothyronine for peak identification CRS; LIOTHYRONINE SODIUM [GREEN BOOK]; LIOTHYRONINE SODIUM [ORANGE BOOK]; NCGC00256816-01; AC-31934; AS-13674; LIOTHYRONINE SODIUM [EP MONOGRAPH]; LIOTHYRONINE SODIUM [USP MONOGRAPH]; NS00078989; SW219577-1; D01011; F20556; 3,5,3a(2)-Triiodo-L-thyronine monosodium salt; Q930170; 3,3',5-Triiodo-L-thyronine sodium salt, >=95% (HPLC); Liothyronine sodium, European Pharmacopoeia (EP) Reference Standard; 3,3',5-Triiodo-L-thyronine sodium salt, powder, BioReagent, suitable for cell culture; 3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]-L-alanine monosodium s alt; Liothyronine for peak identification, European Pharmacopoeia (EP) Reference Standard; 3,3',5-Triiodo-L-thyronine sodium salt, gamma-irradiated, powder, BioXtra, suitable for cell culture; Liothyronine sodique別名
